Dermata Therapeutics, Inc. — All Filings
341 total filings on record
Public companies registered with the SEC are required to file periodic reports, disclosures, and notices throughout the year. The most important are the 10-K (annual report), 10-Q (quarterly report), and 8-K (material event notice). Use the filters below to narrow by form type.
All
10-K
10-K/A
10-Q
3
4
424B3
424B4
424B5
8-A12B
8-K
ARS
CERT
CORRESP
D
D/A
DEF 14A
DEFA14A
DRS
DRS/A
DRSLTR
EFFECT
FWP
POS EX
PRE 14A
RW
S-1
S-1/A
S-1MEF
S-3
S-8
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SCHEDULE 13D/A
SCHEDULE 13G
SCHEDULE 13G/A
SEC STAFF LETTER
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| DEFA14A | DEFA14A | 0001641172-25-013238 | Jun 2, 2025 | — |
| ARS | ARS | 0001641172-25-013239 | Jun 2, 2025 | Dec 31, 2024 |
| PRE 14A | PRE 14A | 0001641172-25-012257 | May 23, 2025 | — |
| 8-K | 8-K | 0001641172-25-011873 | May 21, 2025 | May 20, 2025 |
| 8-K | 8-K | 0001641172-25-011286 | May 16, 2025 | May 14, 2025 |
| SCHEDULE 13G/A | — | 0001172661-25-002251 | May 15, 2025 | — |
| 8-K | 8-K | 0001641172-25-010112 | May 14, 2025 | — |
| 10-Q | 10-Q | 0001641172-25-010111 | May 14, 2025 | Mar 31, 2025 |
| SCHEDULE 13G/A | — | 0001213900-25-041511 | May 9, 2025 | — |
| 424B3 | — | 0001641172-25-005881 | Apr 23, 2025 | — |
| EFFECT | — | 9999999995-25-001212 | Apr 23, 2025 | — |
| UPLOAD | — | 0000000000-25-004185 | Apr 21, 2025 | — |
| CORRESP | — | 0001641172-25-005582 | Apr 21, 2025 | — |
| S-3 | FORM S-3 | 0001654954-25-004304 | Apr 15, 2025 | — |
| 8-K | FORM 8-K | 0001654954-25-004265 | Apr 15, 2025 | — |
| SCHEDULE 13D/A | — | 0001641172-25-003085 | Apr 7, 2025 | — |
| SCHEDULE 13D/A | — | 0001641172-25-002621 | Apr 3, 2025 | — |
| 8-K | FORM 8-K | 0001654954-25-003552 | Mar 28, 2025 | Mar 27, 2025 |
| 8-K | FORM 8-K | 0001654954-25-003372 | Mar 27, 2025 | — |
| 8-K | FORM 8-K | 0001654954-25-003305 | Mar 25, 2025 | — |
| 8-K | FORM 8-K | 0001654954-25-002886 | Mar 17, 2025 | — |
| 10-K | FORM 10-K | 0001654954-25-002885 | Mar 17, 2025 | Dec 31, 2024 |
| SCHEDULE 13G/A | — | 0001172661-25-001304 | Feb 14, 2025 | — |
| SCHEDULE 13D/A | — | 0001493152-25-006502 | Feb 13, 2025 | — |
| 424B3 | 424B3 | 0001654954-25-001172 | Feb 5, 2025 | — |
| EFFECT | — | 9999999995-25-000328 | Feb 5, 2025 | — |
| D/A | — | 0001493152-25-004861 | Feb 4, 2025 | — |
| UPLOAD | — | 0000000000-25-001141 | Feb 3, 2025 | — |
| CORRESP | — | 0001654954-25-001100 | Feb 3, 2025 | — |
| S-3 | S-3 | 0001654954-25-000940 | Jan 30, 2025 | — |
| D | — | 0001493152-25-004008 | Jan 28, 2025 | — |
| SCHEDULE 13G | — | 0001213900-25-007608 | Jan 28, 2025 | — |
| SCHEDULE 13D/A | — | 0001493152-25-003484 | Jan 23, 2025 | — |
| 8-K | FORM 8-K | 0001654954-25-000681 | Jan 23, 2025 | Jan 21, 2025 |
| 4 | PRIMARY DOCUMENT | 0001654954-25-000692 | Jan 23, 2025 | Jan 21, 2025 |
| 4 | FORM 4 | 0001654954-25-000693 | Jan 23, 2025 | Jan 21, 2025 |
| 4 | PRIMARY DOCUMENT | 0001654954-25-000690 | Jan 23, 2025 | Jan 21, 2025 |
| 4 | PRIMARY DOCUMENT | 0001654954-25-000691 | Jan 23, 2025 | Jan 21, 2025 |
| 8-K | FORM 8-K | 0001654954-25-000570 | Jan 21, 2025 | Jan 17, 2025 |
| 4 | FORM 4 | 0001654954-25-000396 | Jan 14, 2025 | Jan 13, 2025 |
| 4 | PRIMARY DOCUMENT | 0001654954-25-000397 | Jan 14, 2025 | Jan 13, 2025 |
| 4 | FORM 4 | 0001654954-25-000398 | Jan 14, 2025 | Jan 13, 2025 |
| 4 | FORM 4 | 0001654954-25-000399 | Jan 14, 2025 | Jan 13, 2025 |
| 4 | FORM 4 | 0001654954-25-000400 | Jan 14, 2025 | Jan 13, 2025 |
| 4 | PRIMARY DOCUMENT | 0001654954-25-000409 | Jan 14, 2025 | Jan 13, 2025 |
| 4 | PRIMARY DOCUMENT | 0001654954-25-000410 | Jan 14, 2025 | Jan 13, 2025 |
| 4 | FORM 4 | 0001654954-25-000411 | Jan 14, 2025 | Jan 13, 2025 |
| 4 | FORM 4 | 0001654954-25-000412 | Jan 14, 2025 | Jan 13, 2025 |
| 4 | PRIMARY DOCUMENT | 0001654954-25-000413 | Jan 14, 2025 | Jan 13, 2025 |
| 4 | FORM 4 | 0001654954-25-000414 | Jan 14, 2025 | Jan 13, 2025 |